Previous 10 | Next 10 |
home / stock / mkkgy / mkkgy news
2023-11-12 20:42:37 ET Summary Evotec SE's appeal is based on its valuation and upside potential in the drug discovery and development sector. The company's financial performance is average, with negative margins and subpar business model specifics for 2022. Despite some issue...
2023-11-09 14:07:10 ET Merck KGaA (MKGAF) Q3 2023 Earnings Conference Call November 09, 2023, 08:00 ET Company Participants Constantin Fest - Head, IR Belen Garijo - Chair & CEO Helene von Roeder - CFO Kai Beckmann - CEO, Electronics Peter Guenter - C...
2023-11-05 02:15:00 ET Summary Jiangsu Hengrui Pharma out-licensed global rights (ex-China) for its next-gen PARP1 inhibitor to Germany’s Merck KGaA. BioLineRx, an Israeli biotech, out-licensed China rights to a stem cell mobilizer for multiple myeloma and stem cell disease...
2023-10-16 12:27:11 ET Summary Sartorius is facing challenging business conditions due to destocking and delayed customer investment. The company's ability to maintain high levels of sustained growth is a concern due to increasing competition and financing costs. We downgrade ...
2023-09-20 14:02:43 ET Summary Exscientia plc has partnered with Merck KGaA for AI-powered drug discovery in complex disease segments, solidifying its industry positioning. AI is gaining traction in the healthcare industry, with projections estimating the AI drug discovery market ...
2023-09-20 07:47:47 ET More on Exscientia and AI drug discovery Seeking Alpha’s Quant Rating on Exscientia Exscientia Is Worth The AI-Driven Speculation Exscientia gains as enrollments begin for cancer trial AI to represent 11% of healthcare budgets in...
2023-08-13 11:40:00 ET Summary Merck KGaA reported disappointing Q2 results with a decrease in gross profit and EBIT compared to the previous year. The company remains confident in its 2025 targets despite reducing its full-year guidance for 2023. Anticipated double-digit reve...
2023-08-05 07:21:02 ET Merck KGaA (MKGAF) Q2 2023 Earnings Conference Call August 3, 2023 8:00 a.m. ET Company Participants Constantin Fest - Head of Investor Relations Belén Garijo - Chief Executive Officer Helene von Roeder - Chief Financial Officer Ma...
2023-07-26 15:04:29 ET The World Health Organization updated its Essential Medicines List on Wednesday without adding a class of weight loss medications called glucagon-like peptide-1 (GLP-1) receptor agonists as a treatment for obesity. The list designed to guide state procurement deci...
Data Vault Holdings, Inc. and p-Chip Corporation to Connect Platforms through Enabling IP Licensing Agreement PR Newswire Microtransponder Technology Adds to Web 3.0 Anchor Options and a Host of Capabilities to DataVault's Data Management Platform NEW YOR...
News, Short Squeeze, Breakout and More Instantly...
Merck KGaA ADR Company Name:
MKKGY Stock Symbol:
OTCMKTS Market:
Pfizer Inc (NYSE: PFE) agreed to donate the rights of royalties from sales of cancer drug Bavencio (avelumab) to the American Associ...
Merck KGaA (OTC: MKGAF) (OTC: MKKGY) says its two Phase 3 EVOLUTION trials (evolutionRMS 1 and evolutionRMS 2) of evobruti...
Repligen Corporation (NASDAQ: RGEN) agreed to acquire Sweden-based privately-held Metenova. Metenova is projected to generate reven...